Fertility and Sterility
Volume 84, Issue 6 , Pages 1561-1573 , December 2005

Innovations in fertility preservation for patients with gynecologic cancers

  • Wen-Shiung Liou, M.D.

      Affiliations

    • Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, Stanford University School of Medicine, Palo Alto, California, USA
    • Department of Obstetrics and Gynecology, Veteran General Hospital, Kaohsiung, Taiwan
    • ,
  • O.W. Stephanie Yap, M.D.

      Affiliations

    • Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, Stanford University School of Medicine, Palo Alto, California, USA
    • ,
  • John K. Chan, M.D.

      Affiliations

    • Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, Stanford University School of Medicine, Palo Alto, California, USA
    • ,
  • Lynn M. Westphal, M.D.

      Affiliations

    • Division of Reproductive Endocrinology, Department of Gynecology and Obstetrics, Stanford University School of Medicine, Palo Alto, California
    • Corresponding Author InformationReprint requests: Lynn M. Westphal, M.D., Stanford University School of Medicine, Department of Obstetrics and Gynecology, 300 Pasteur Drive, Stanford, California 94305-5317 (FAX: 650-723-7737).

Received 9 February 2005 ,Accepted 7 April 2005.

References 

  1. Jelfs P , Giles G , Shugg D . Cancer in Australia 1986–1988. Cancer series No. 2. Australian Institute of Health and Welfare and Australasian Association of Cancer Registries . Canberra ACT: Australian Government Publishing Services; 1994;
  2. Van der Vange N , Weverling G , Ketting B , Ankum WM , Samlal R , Lammes FB . The prognosis of cervical cancer associated with pregnancy (a matched cohort study) . Obstet Gynecol . 1995;85:1022–1026
  3. Chan PG , Sung HY , Sawaya GF . Changes in cervical cancer incidence after three decades of screening US women less than 30 years old . Obstet Gynecol . 2003;102:765–773
  4. Mestwerdt G . Probeexzision und Kolposkopie in de Fruehdiagnose des Portiokarzinoms . Zentralbl Gynaekol . 1947;4:326–332
  5. Kolstad P . Follow-up study of 232 patients with stage IA1 and 411 patients with stage Ia2 squamous cell carcinoma of the cervix (microinvasive carcinoma) . Gynecol Oncol . 1989;33:265–272
  6. Morris M , Mitchell MF , Silva EG , Copeland LJ , Gershenson DM . Cervical conization as definitive therapy for early invasive carcinoma of the cervix . Gynecol Oncol . 1993;51:193–196
  7. National Institutes of Health Consensus Development Panel . In: National Institutes of Health Consensus Development Conference Statement (cervical cancer, 1-3 April 1996) . Bethesda, MD: Monogr Natl Cancer Inst; 1996;p. vii–xix 21
  8. Schorge JO , Lee KR , Sheets EE . Prospective management of stage IA1 cervical adenocarcinoma by conization alone to preserve fertility (a preliminary report) . Gynecol Oncol . 2000;78:217–220
  9. McHale MT , Le TD , Burger RA , Gu M , Rutgers JL , Monk BJ . Fertility sparing treatment for in situ and early invasive adenocarcinoma of the cervix . Obstet Gynceol . 2001;98(5 Pt 1):726–731
  10. El-Bastawissi AY , Becker TM , Daling JR . Effect of cervical carcinoma in situ and its management on pregnancy outcome . Obstet Gynecol . 1999;93:207–212
  11. Yaegashi N , Sato S , Inoue Y , Noda K , Yajma A . Conservative surgical treatment in cervical cancer with 3 to 5 mm stromal invasion in the absence of confluent invasion and lymph-vascular space involvement . Gynecol Oncol . 1994;54:333–337
  12. Girardi F , Burghardt E , Pickel H . Small FIGO stage IB cervical cancer . Gynecol Oncol . 1994;55(3 Pt 1):427–432
  13. Morrow CP , Curtin JP , Townsend DE . In: Synopsis of gynecologic oncology . 4th ed.. New York: Churchill Livingstone; 1993;p. 111–152
  14. Dargent D , Brun J-L , Roy M . La trachelectomieelargie (T.E.). Unealternative e l’hysterectomie radicale dans le traitement des cancers infiltrants developpes sur la face externe du col uterin . J Obstet Gynecol . 1994;2:285–292
  15. Shepherd J , Crawford R , Oram D . Radical trachelectomy (a way to preserve fertility in the treatment of early cervical cancer) . Br J Obstet Gynecol . 1998;105:912–916
  16. Covens A , Shaw P , Murphy J , DePetrillo D , Lickrish G , Laframboise S , et al.   Is radical trachelectomy a safe alternative to a radical hysterectomy for patients with stage IA-B carcinoma of the cervix? . Cancer . 1999;86:2273–2279
  17. Schlaerth JB , Spirtos NM , Schlaerth AC . Radical trachelectomy and pelvic lymphadenectomy with uterine preservation in the treatment of cervical cancer . Am J Obstet Gynecol . 2003;188:29–34
  18. Roy M , Plante M . Radical vaginal trachelectomy . In:  Querleu D ,  Childers JM ,  Dargent D editor. Laparoscopic surgery in gynecologic oncology . London: Blackwell Science; 1999;p. 78–89
  19. Burnett AF , Roman LD , O’Meara AT , Morrow CP . Radical vaginal trachelectomy and pelvic lymphadenectomy for preservation of fertility in early cervical carcinoma . Gynecol Oncol . 2003;88:419–423
  20. Roy M , Plante M . Pregnancies after radical vaginal trachelectomy for early-stage cervical cancer . Am J Obstet Gynecol . 1998;179:1491–1496
  21. Dargent D , Martin X , Sacchetoni A , Mathevet P . Laparoscopic vaginal radical trachelectomy (a treatment to preserve the fertility of cervical carcinoma patients) . Cancer . 2000;88:1877–1882
  22. Dargent D , Franzosi F , Ansquer Y , Matrin X , Mathevet P , Adeline P . Extended trachelectomy relapse (plea for involvement in the medical decision) . Bull Cancer . 2002;89:1027–1030
  23. Mathevet P , Laszlo de Kaszon E , Dargent D . Fertility preservation in early cervical cancer . Gynecol Obstet Fertil . 2003;31:706–712
  24. Plante M , Renaud MC , Francois H , Roy M . Vaginal radical trachelectomy: an oncologically safe fertility-preserving surgery. An updated series of 72 cases and review . Gynecol Oncol . 2004;94:614–623
  25. Steed H , Covens A . Radical vaginal trachelectomy and laparoscopic pelvic lymphadenectomy for preservation of fertility . Postgrad Obstet Gynecol . 2003;23:1–6
  26. Covens A . Preserving fertility in early stage cervical cancer with radical trachelectomy . Contemp Obstet Gynecol . 2003;48:46–66
  27. Shepherd JH , Mould T , Oram DH . Radical trachelectomy in early stage carcinoma of the cervix (outcome as judged by recurrence and fertility rates) . BJOG . 2001;108:882–885
  28. Morice P , Dargent D , Haie-Meder C , Duvillard P , Castaigne D . First case of a centropelvic recurrence after radical trachelectomy (literature review and implications for the preoperative selection of patients) . Gynecol Oncol . 2004;92:1002–1005
  29. Boyce JG , Fruchter RG , Nicastri AD , Deregt RH , Pah-Choon A , Reinis M , et al.   Vascular invasion in stage I carcinoma of the cervix . Cancer . 1984;53:1175–1180
  30. Morice P , Petrow P , Pomel C . Radical trachelectomy (a need for careful preoperative assessment) . Am J Obstet Gynecol . 2003;189:1515
  31. Bernardini M , Barrett J , Seaward G , Covens A . Pregnancy outcomes in patients after radical trachelectomy . Am J Obstet Gynecol . 2003;189:1378–1382
  32. Saling E . Prevent habitual abortion and prematurity by early total occlusion of the external os uteri . Eur J Obstet Gynecol Reprod Biol . 1984;17:165–170
  33. Benedetti-Panici P , Maneschi F , D’Andrea G , Cutillo G , Rabitti C , Congiu M , et al.   Early cervical carcinoma (the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study) . Cancer . 2000;88:2267–2274
  34. Borgstein PJ , Pijpers R , Comans EF , van Diest PJ , Boom RP , Meijer S . Sentinel lymph node biopsy in breast cancer (guidelines and pitfalls of lymphoscintigraphy and gamma probe detection) . J Am Coll Surg . 1998;186:275–283
  35. Dargent D , Martin X , Mathevet P . Laparoscopic assessment of sentinel lymph node in early stage cervical cancer . Gynecol Oncol . 2000;79:411–415
  36. Martínez-Palones JM , Gil-Moreno A , Pérez-Benavente MA , Roca I , Xercavins J . Intraoperative sentinel node identification in early cervical cancer using a combination of radiolabeled albumin injection and isosulfan blue dye injection . Gynecol Oncol . 2004;92:845–850
  37. Gitsch G , Hanzal E , Jensen D , Hacker NF . Endometrial cancer in premenopausal women 45 years and younger . Obstet Gynecol . 1995;85:504–508
  38. Randall TC , Kurman RJ . Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40 . Obstet Gynecol . 1997;90:434–440
  39. Morrow CP , Bundy BN , Kurman RJ , Creasman WT , Heller P , Homesley HD , et al.   Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium (a gynecologic oncology group study) . Gynecol Oncol . 1991;40:55–65
  40. Kimmig R , Strowitzki T , Muller-Hocker J , Kurzl R , Korell M , Hepp H . Conservative treatment of endometrial cancer permitting subsequent triplet pregnancy . Gynecol Oncol . 1995;58:255–257
  41. Bokhman JV , Chepick OF , Volkova AT , Vishnevsky AS . Adjuvant hormone therapy of primary endometrial carcinoma with oxyprogesterone carproate . Gynecol Oncol . 1981;11:371–378
  42. Emons G , Schroder B , Ortmann O , Westphalen S , Schulz KD , Schally A . High affinity binding and direct antiproliferative effects of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell line . J Clin Endocrinol Metab . 1993;77:1458–1464
  43. Kim YB , Holschneider CH , Ghosh K , Nieberg R , Montz FJ . Progestin alone as primary treatment for endometrial carcinoma in premenopausal women . Cancer . 1997;79:320–327
  44. Kaku T , Yoshikawa H , Tsuda H , Sakamoto A , Fukunaga M , Kuwabara Y , et al.   Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women (central pathologic review and treatment outcome) . Cancer Lett . 2001;167:39–48
  45. Gotlieb WH , Beiner ME , Shalmon B , Korach Y , Segal Y , Zmira N , et al.   Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer . Obstet Gynecol . 2003;102:718–725
  46. Farhi D , Nosanchuk J , Silverberg S . Endometrial adenocarcinoma in women under 25 years of age . Obstet Gynecol . 1986;68:741–745
  47. Thigpen JT , Brady MF , Alvarez RD , Adelson MD , Homesley HD , Manetta A , et al.   Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma (a dose-response study by the gynecologic oncology group) . J Clin Oncol . 1999;17:1736–1744
  48. Vinker S , Shani A , Open M , Fenig E , Dgani R . Conservative treatment of adenocarcinoma of the endometrium in young patients. Is it appropriate? . Eur J Obstet Gynecol Reprod Biol . 1999;83:63–66
  49. Jadoul P , Donnez J . Conservative treatment may be beneficial for young women with atypical endometrial hyperplasia or endometrial adenocarcinoma . Fertil Steril . 2003;80:1315–1324
  50. Lowe MP , Cooper BC , Sood AK , Davis WA , Syrop CH , Sorosky JI . Implementation of assisted reproductive technologies following conservative management of FIGO grade I endometrial adenocarcinoma and/or complex hyperplasia with atypia . Gynecol Oncol . 2003;91:569–572
  51. Wang CB , Wang CJ , Huang HJ , Hsueh S , Chou HH , Soong YK , et al.   Fertility-preserving treatment in young patients with endometrial adenocarcinoma . Cancer . 2002;94:2192–2198
  52. Evans-Metcalf ER , Brooks SE , Reale FR , Baker SP . Profile of women 45 years of age and younger with endometrial cancer . Obstet Gynecol . 1998;91:349–354
  53. Eifel P , Hendrickson M , Ross J , Ballon S , Martinez A , Kempson R . Simultaneous presentation of carcinoma involving the ovary and the uterine corpus . Cancer . 1982;50:163–170
  54. Crissman JD , Azoury RS , Barnes AE , Schellhas HF . Endometrial carcinoma in women 40 years of age or younger . Obstet Gynecol . 1981;57:699–704
  55. Kullander S . Treatment of endometrial cancer with GnRH analogues . Recent Result Cancer Res . 1992;124:69–73
  56. Perl V , Schally AV , Comaru-Schally AM , Marquez J , Dabancens A , Navarro C . Use of D-Trp6-LHRH in endometrial adenocarcinoma . 1987; Proceedings from the XXII Congreso Chileno de Obstetrica y Ginecologia, Santiago, Chile 2:7
  57. Montz FJ , Bristow RE , Bovicelli A , Tomacruz R , Kurman RJ . Intrauterine progesterone treatment of early endometrial cancer . Am J Obstet Gynecol . 2002;186:651–657
  58. Sardi J , Anchezar Henry JP , Paniceres G , Gomez Rueda N , Vighi S . Primary hormonal treatment for early endometrial carcinoma . Eur J Gynecol Oncol . 1998;19:565–568
  59. Heintz AP , Odicino F , Maisonneuve P , Beller U , Benedet JL , Creasman WT , et al.   Carcinoma of ovary. FIGO Annual Report . Int J Gynaecol Obstet . 2003;83(Suppl 1):135–166
  60. Duska LR , Chang YC , Flynn CE , Chen AH , Goodman A , Fuller AF , et al.   Epithelial ovarian carcinoma in the reproductive age group . Cancer . 1999;85:2623–2629
  61. Plaxe SC , Braly PS , Freddo JL , McClay E , Kirmani S , Howell SB . Profiles of women age 30–39 and age less than 30 with epithelial ovarian cancer . Obstet Gynecol . 1993;81:651–654
  62. Rodriguez M , Nguyen HN , Averette HE , Steren AJ , Penalver MA , Harrison T , et al.   National survey of ovarian carcinoma XII. Epithelial ovarian malignancies in women less than or equal to 25 years of age . Cancer . 1994;73:1245–1250
  63. DiSaia PJ . Fertility-sparing treatment of patients with ovarian cancer . Compr Ther . 1990;16:35–42
  64. McHale M , DiSaia P . Fertility-sparing treatment of patients with ovarian cancer . Compr Ther . 1999;25:144–150
  65. Zanetta G , Chiari S , Rota S , Bratina G , Maneo A , Torri V , et al.   Conservative surgery for stage I ovarian carcinoma in women of childbearing age . Br J Obstet Gynecol . 1997;104:1030–1035
  66. Colombo N , Chiari S , Maggioni A , Bocciolone L , Torri V , Mangioni C . Controversial issues in the management of early epithelial ovarian cancer (conservative surgery and the role of adjuvant therapy) . Gynecol Oncol . 1994;55(3 Pt 2):S47–S51
  67. Schilder JM , Thompson AM , DePriest PD , Ueland FR , Cibull ML , Kryscio RJ , et al.   Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy . Gynecol Oncol . 2002;87:1–7
  68. Seiden MV , Spitzer TR , McAfee S , Fuller AF . Successful pregnancy after high-dose cyclophosphamide, carboplatinum, and taxol with peripheral blood stem cell transplant in a young woman with ovarian carcinoma . Gynecol Oncol . 2001;83:412–414
  69. Morice P , Wicart-Poque F , Rey A , El-Hassan J , Pautier P , Lhomme C , et al.   Results of conservative treatment in epithelial ovarian cancer . Cancer . 2001;92:2412–2418
  70. Crispens MA . Borderline ovarian tumors (a review of the recent literature) . Curr Opin Obstet Gynceol . 2003;15:39–43
  71. Trimble CL , Trimble EL . Management of epithelial ovarian tumors of low malignant potential . Gynecol Oncol . 1994;(3 Pt 255):52–61
  72. Silva EG , Tornos C , Zhuang Z , Merino MJ , Gershenson DM . Tumor recurrence in stage I ovarian serous neoplasms of low malignant potential . Int J Gynecol Pathol . 1998;17:1–6
  73. Gotlieb WH , Flikker S , Davidson B , Korach Y , Kopolovic J , Ben-Baruch G , et al.   Borderline tumors of the ovary (fertility treatment, conservative management, and pregnancy outcome) . Cancer . 1998;82:141–146
  74. Morice P , Camatte S , El Hassan J , Pautier P , Duvillard P , Castaigne D . Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors . Fertil Steril . 2001;75:92–96
  75. Morris RT , Gershenson DM , Silva EG , Follen M , Morris M , Wharton JT . Outcome and reproductive function after conservative surgery for borderline ovarian tumors . Obstet Gynecol . 2000;95:541–547
  76. Chan JK , Lin YG , Loizzi V , Ghobriel M , DiSaia PJ , Berman ML . Borderline ovarian tumors in reproductive-age women . J Reprod Med . 2003;48:756–760
  77. Tazelaar HD , Bostwick DG , Ballon SC , Hendrickson MR , Kempson RL . Conservative treatment of borderline ovarian tumors . Obstet Gynecol . 1985;66:417–422
  78. Tamakoshi K , Kikkawa F , Nakashima N , Tamakoshi A , Kawai M , Furuhashi Y , et al.   Clinical behavior of borderline ovarian tumors (a study of 150 cases) . J Surg Oncol . 1997;64:147–152
  79. Zanetta G , Rota S , Chiari S , Bonazzi C , Bratina G , Mangioni C . Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma (a prospective study) . J Clin Oncol . 2001;19:2658–2664
  80. Lim-Tan SK , Cajigas HE , Scully RE . Ovarian cystectomy for serous borderline tumors (a follow-up study of 35 cases) . Obstet Gynecol . 1988;72:775–781
  81. Gershenson DM , Silva EG , Tortolero-Luna G , Levenback C , Morris M , Tornos C . Serous borderline tumors of the ovary with noninvasive peritoneal implants . Cancer . 1998;83:2157–2163
  82. Gershenson DM , Silva EG , Levy L , Burke TW , Wolf JK , Tornos C . Ovarian serous borderline tumors of the ovary with invasive peritoneal implants . Cancer . 1998;82:1096–1103
  83. Camatte S , Morice P , Pautier P , Atallah D , Duvillard P , Castaigne D . Fertility results after conservative treatment of advanced stage serous borderline tumor of the ovary . BJOG . 2002;109:376–380
  84. Williams S , Blessing JA , Liao SY , Ball H , Hanjani P . Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin (a trial of the Gynecologic Oncology Group) . J Clin Oncol . 1994;12:701–706
  85. Gershenson DM . Update on malignant ovarian germ cell tumors . Cancer . 1993;71:1581–1590
  86. Schwartz PE . Combination chemotherapy in management of ovarian germ cell malignancies . Obstet Gynecol . 1984;64:564–572
  87. Gershenson DM . Management of early ovarian cancer (germ cell and sex cord-stromal tumors) . Gynecol Oncol . 1994;55(3 Pt 2):s62–s72
  88. Schwartz PE , Chambers SK , Chambers JT , Kohorn E , McIntosh S . Ovarian germ cell malignancies (the Yale University experience) . Gynecol Oncol . 1992;45:26–31
  89. Peccatori F , Bonazzi C , Chiari S , Landoni F , Colombo N , Mangioni C . Surgical management of malignant ovarian germ cell tumors (10 years’ experience of 129 patients) . Obstet Gynecol . 1995;86:367–372
  90. Sagaes S , Kudo R . Surgery for germ cell tumors . Semin Surg Oncol . 2000;19:76–81
  91. Low JJ , Perrin LC , Crandon AJ , Hacker NF . Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors . Cancer . 2000;89:391–398
  92. Hoskins WJ , Perez CA , Young RC . In: Principles and practice of gynecologic oncology . 3rd ed.. Philadelphia: Lippincott Williams & Wilkins; 2000;p. 1059–1073
  93. Makar AP , Trope C . Fertility preservation in gynecologic cancer . Acta Obstet Gynecol Scand . 2001;80:794–802
  94. Gershenson DM , Morris M , Cangir A , Kavanagh JJ , Stringer CA , Edwards CL , et al.   Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin . J Clin Oncol . 1990;8:715–720
  95. Zanetta G , Bonazzi C , Cantu M , Binidagger S , Locatelli A , Bratina G , et al.   Survival and reproductive function after treatment of malignant germ cell ovarian tumors . J Clin Oncol . 2001;15:1015–1020
  96. Perrin LC , Low J , Nicklin JL , Ward BG , Crandon AJ . Fertility and ovarian function after conservative surgery for germ cell tumors of the ovary . Aust N Z J Obstet Gynecol . 1999;39:243–245
  97. Tangir J , Zelterman D , Ma W , Schwartz PE . Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary . Obstet Gynecol . 2003;101:251–257
  98. Gershenson D . Menstrual and reproductive function after treatment with combination chemotherapy for malignant ovarian germ cell tumors . J Clin Oncol . 1988;6:270–275
  99. Schover LR , Rybicki LA , Martin BA , Bringelsen KA . Having children after cancer (a pilot survey of survivors’ attitudes and experience) . Cancer . 1999;86:687–709
  100. Ginsburg ES , Yanushpolsky EH , Jackson KV . In vitro fertilization for cancer patients and survivors . Fertil Steril . 2001;75:705–710
  101. Oktay K , Buyuk E , Davis O , Yermakova I , Veeck L , Rosenwaks Z . Fertility preservation in breast cancer patients (IVF and embryo cryopreservation after ovarian stimulation with tamoxifen) . Hum Reprod . 2003;18:90–95
  102. Oktay K , Buyuk E , Akar M , Rosenwaks Z , Libertella N . Fertility preservation in breast cancer patients (a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation) . J Clin Oncol . 2005;23:4347–4353
  103. Oktay K , Buyuk E , Rosenwaks Z . Novel use of an aromatase inhibitor for fertility preservation via embryo cryopreservation in endometrial cancer (a case report) . Fertil Steril . 2003;80(Suppl 3):144
  104. Juretzka MM , O’Hanlan KA , Katz SL , El-Danasouń I , Westphal LM . Embryo cryopreservation after diagnosis of Stage IIB endometrial cancer and subsequent pregnancy in gestational cancer . Fertil Steril . 2005;83:1041
  105. Donnez J , Bassil S . Indications for cryopreservation of ovarian tissue . Human Reprod Update . 1998;4:248–259
  106. Gosden RG , Baird DT , Wade JC , Webb R . Restoration of fertility to oophorectomized sheep by ovarian autograft stored at –96°C . Hum Reprod . 1994;9:597–603
  107. Oktay K , Economos K , Kan M , Rucinski J , Veeck L , Rosenwaks Z . Endocrine function and oocyte retrieval after autologous transplantation of ovarian cortical strips to the forearm . JAMA . 2001;286:1490–1493
  108. Oktay K , Aydin BA , Karlikaya G . A technique for laparoscopic transplantation of frozen-banked ovarian tissue . Fertil Steril . 2001;75:1212–1216
  109. Donnez J , Dolmans MM , Jadoul P , Pirard C , Suifflet J , Martinez-Madrid B , et al.   Livebirth after orthotopic transplantation of cryopreserved ovarian tissue . Lancet . 2004;364:1405–1410
  110. Oktay K , Buyuk E , Veeck L , Zaninovic N , Xu K , Takeuchi T , et al.   Embryo development after heterotopic transplantation of cryopreserved ovarian tissue . Lancet . 2004;363:837–840
  111. Oktay K , Buyuk E . Ovarian transplantation in humans (indications, techniques and the risk of reseeding cancer) . Eur J Obstet Gynecol Reprod Biol . 2004;113(Suppl 1):s45–s47

PII: S0015-0282(05)03324-8

doi: 10.1016/j.fertnstert.2005.03.087

Fertility and Sterility
Volume 84, Issue 6 , Pages 1561-1573 , December 2005

Article Tools